Cardiac involvement in sarcoidosis: Evolving concepts in diagnosis and treatment
Main Article Content
Abstract
Clinically evident cardiac involvement has been noted in at least 2 to 7% of patients with sarcoidosis, but occult involvement is much higher (> 20%). Cardiac Sarcoidosis (CS) is often not recognized as an antemortem, as sudden death may be the presenting feature. Cardiac involvement may occur at any point during the course of sarcoidosis and may occur in the absence of pulmonary or systemic involvement. Sarcoidosis can involve any part of the heart. The prognosis of CS is related to the extent and site(s) of involvement. Most deaths due to CS are due to arrhythmias or conduction defects, but granulomatous infiltration of the myocardium may cause progressive and ultimately lethal cardiomyopathy. The definitive diagnosis of isolated CS is difficult and the yield of Endomyocardial Biopsies (EMB) is low. Treatment of CS is often warranted even in the absence of histologic proof. Radionuclide scans are integral to the diagnosis. Gadolinium-enhanced cardiac magnetic imaging scans and 18Fluorodeoxyglucose (18FDG)-Positron Emission Tomography (PET) are the key imaging modalities to diagnose CS. The prognosis of CS is variable, but mortality rates of untreated CS are high. Randomized therapeutic trials have not been done, but corticosteroids (alone or combined with additional immunosuppressive agents) are the mainstay of therapy. Additionally, anti-arrhythmic agents and therapy for heart failure are often required. Because of the potential for sudden cardiac death, an Implantable Cardioverter-Defibrillator (ICD) should be placed in any patient with CS and serious ventricular arrhythmias or heart block and should be considered for cardiomyopathy. Cardiac transplantation is a viable option for patients with end-stage CS refractory to medical therapy.
Downloads
Article Details
Copyright (c) 2021 Lynch III JP, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Sayah DM, Bradfield JS, Moriarty JM, Belperio JA, Lynch JP (2017) Cardiac Involvement in Sarcoidosis: Evolving Concepts in Diagnosis and Treatment. Semin Respir Crit Care Med 38: 477-498. Link: https://bit.ly/309hJhI
Ayyala US, Nair AP, Padilla ML (2008) Cardiac sarcoidosis. Clin Chest Med 29: 493-508. Link: https://bit.ly/3Gp4rx4
Nunes H, Freynet O, Naggara N, Soussan M, Weinman P, et al. (2010) Cardiac sarcoidosis. Semin Respir Crit Care Med 31: 428-441. Link: https://bit.ly/3ozTlPN
Zhou Y, Lower EE, Li HP, Costea A, Attari M, et al. (2017) Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival. Chest 151: 139-148. Link: https://bit.ly/3y3mtSx
Padala SK, Peaslee S, Sidhu MS, Steckman DA, Judson MA (2017) Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis. Int J Cardiol 227: 565-570. Link: https://bit.ly/3dwpAZJ
Kinney EL, Jackson GL, Reeves WC, Zelis R (1980) Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients. Am J Med 68: 497-503. Link: https://bit.ly/3DA905C
Fahy GJ, Marwick T, McCreery CJ, Quigley PJ, Maurer BJ (1996) Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 109: 62-66. Link: https://bit.ly/31Dp4GC
Perry A, Vuitch F (1995) Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 119: 167-172. Link: https://bit.ly/3pBfWdN
Roberts WC, McAllister HA Jr, Ferrans VJ (1977) Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 63: 86-108. Link: https://bit.ly/3du08E7
Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58: 1204-1211. Link: https://bit.ly/3dB6IZm
Virmani R, Bures JC, Roberts WC (1980) Cardiac sarcoidosis; a major cause of sudden death in young individuals. Chest 77: 423-428. Link: https://bit.ly/30530Em
Bagwan IN, Hooper LV, Sheppard MN (2011) Cardiac sarcoidosis and sudden death. The heart may look normal or mimic other cardiomyopathies. Virchows Arch 458: 671-678. Link: https://bit.ly/3y4Vx4N
Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, et al. (1976) Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 278: 455-469. Link: https://bit.ly/3y3Vk1I
Hu X, Carmona EM, Yi ES, Pellikka PA, Ryu J (2016) Causes of death in patients with chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 33: 275-280. Link: https://bit.ly/33cvqxx
Stewart RE, Graham DM, Godfrey GW, Friedman HZ, Das SK, et al. (1988) Rapidly progressive heart failure resulting from cardiac sarcoidosis. Am Heart J 115: 1324-1326. Link: https://bit.ly/3dyBhzc
Tavora F, Cresswell N, Li L, Ripple M, Solomon C, et al. (2009) Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 104: 571-577. Link: https://bit.ly/3rQI2ob
Fleming HA, Bailey SM (1981) Sarcoid heart disease. J R Coll Physicians Lond 15: 245-246, 249-253. Link: https://bit.ly/3Go1897
Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, et al. (2001) Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88: 1006-1010. Link: https://bit.ly/3GsPV7d
Zoneraich S, Gupta MP, Mehta J, Zoneraich O, Wessely Z (1974) Myocardial sarcoidosis presenting as acute mitral insufficiency. Chest 66: 452-454. Link: https://bit.ly/33cfY4s
Gozo EG Jr, Cosnow I, Cohen HC, Okun L (1971) The heart in sarcoidosis. Chest 60: 379-388. Link: https://bit.ly/3pwptTm
Bashour FA, McConnell T, Skinner W, Hanson M (1968) Myocardial sarcoidosis. Dis Chest 53: 413-420. Link: https://bit.ly/3ECrMuE
Porter GH (1960) Sarcoid heart disease. N Engl J Med 263: 1350-1357. Link: https://bit.ly/3lOezHF
Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, et al. (2015) Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 131: 624-632. Link: https://bit.ly/3EEkJ4s
Nagai T, Nagano N, Sugano Y, Asaumi Y, Aiba T, et al. (2015) Effect of Corticosteroid Therapy on Long-Term Clinical Outcome and Left Ventricular Function in Patients With Cardiac Sarcoidosis. Circ J 79: 1593-1600. Link: https://bit.ly/3owWgZq
Nagai T, Nagano N, Sugano Y, Asaumi Y, Aiba T, et al. (2016) Effect of Discontinuation of Prednisolone Therapy on Risk of Cardiac Mortality Associated With Worsening Left Ventricular Dysfunction in Cardiac Sarcoidosis. Am J Cardiol 117: 966-971. Link: https://bit.ly/3y47Iim
Cremers JP, Drent M, Bast A, Shigemitsu H, Baughman RP, et al. (2013) Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med 19: 545-561. Link: https://bit.ly/3rNzGxO
Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, et al. (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83: 315-334. Link: https://bit.ly/3pG0eOA
Chapelon-Abric C, Sene D, Saadoun D, Cluzel P, Vignaux O, et al. (2017) Cardiac sarcoidosis: Diagnosis, therapeutic management and prognostic factors. Arch Cardiovasc Dis 110: 456-465. Link: https://bit.ly/3y47SGu
Gallegos C, Oikonomou EK, Grimshaw A, Gulati M, Young BD, et al. (2021) Non-steroidal treatment of cardiac sarcoidosis: A systematic review. Int J Cardiol Heart Vasc 34: 100782. Link: https://bit.ly/31H1OYe
Obi ON, Lower EE, Baughman RP (2021) Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update. Expert Rev Clin Pharmacol 14: 179-210. Link: https://bit.ly/306Mm7t
Uthman I, Touma Z, Khoury M (2007) Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol 26: 2001-2003. Link: https://bit.ly/3oA0CPj
Harper LJ, McCarthy M, Ribeiro Neto ML, Hachamovitch R, Pearson K, et al. (2019) Infliximab for Refractory Cardiac Sarcoidosis. Am J Cardiol 124: 1630-1635. Link: https://bit.ly/3dwr32b
Bakker ALM, Mathijssen H, Azzahhafi J, Swaans MJ, Veltkamp M, et al. (2021) Effectiveness and safety of infliximab in cardiac Sarcoidosis. Int J Cardiol 330: 179-185. Link: https://bit.ly/3GqNLFu
Gilotra NA, Wand AL, Pillarisetty A, Devraj M, Pavlovic N, et al. (2021) Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience. J Card Fail 27: 83-91. Link: https://bit.ly/3y7CmYf
Heymans S, Eriksson U, Lehtonen J, Cooper LT Jr. (2016) The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. J Am Coll Cardiol 68: 2348-2364. Link: https://bit.ly/31HpwDC
Lee PI, Cheng G, Alavi A (2017) The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis. J Nucl Cardiol 24: 19-28. Link: https://bit.ly/3ItAvS5
Shelke AB, Aurangabadkar HU, Bradfield JS, Ali Z, Kumar KS, et al. (2017) Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis. Int J Cardiol 228: 717-722. Link: https://bit.ly/3DF4SBj
Ning N, Guo HH, Iagaru A, Mittra E, Fowler M, et al. (2019) Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis. J Card Fail 25: 307-311. Link: https://bit.ly/3du1rmv
Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, et al. (2018) Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 19: 757-767. Link: https://bit.ly/3ECZrV5
Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, et al. (2018) Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging 11: e007030. Link: https://bit.ly/3Dyoo2v
Shafee MA, Fukuda K, Wakayama Y, Nakano M, Kondo M, et al. (2012) Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis. J Cardiol 60: 448-453. Link: https://bit.ly/3pG1pgS
Greulich S, Gatidis S, Grani C, Blankstein R, Glatthaar A, et al. (2021) Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis. JACC Cardiovasc Imaging. Link: https://bit.ly/3IvFVMv
Mateyo K, Thomeer M (2017) Sarcoidosis around the Globe. Semin Respir Crit Care Med 38: 393-403. Link: https://bit.ly/3dunWb5
Ballul T, Borie R, Crestani B, Daugas E, Descamps V, et al. (2019) Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs. Int J Cardiol 276: 208-211. Link: https://bit.ly/3DFzToV
Johns CJ, Michele TM (1999) The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 78: 65-111. Link: https://bit.ly/3Gt3Pq5
Baughman RP, Field S, Costabel U, Crystal RG, Culver DA, et al. (2016) Sarcoidosis in America. Analysis Based on Health Care Use. Ann Am Thorac Soc 13: 1244-1252. Link: https://bit.ly/3DzUXNv
Hillerdal G, Nou E, Osterman K, Schmekel B (1984) Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 130: 29-32. Link: https://bit.ly/3oEzIpq
Byg KE, Milman N, Hansen S (2003) Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 20: 46-52. Link: https://bit.ly/3pyDwIg
Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, et al. (2006) Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 61: 980-985. Link: https://bit.ly/3pYbLt1
Lopez-Campos JL, Rodriguez-Becerra E, Neumosur Task G, Registry of Interstitial Lung D (2004) Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study. Eur J Epidemiol 19: 155-161. Link: https://bit.ly/3oAW8rD
Mise K, Jurcev-Savicevic A, Goic-Barisic I, Kozul K, Gudelj I (2011) Sarcoidosis and tuberculosis in South Croatia: are there epidemiological similarities or not? Public Health 125: 734-737. Link: https://bit.ly/3IKiQWH
Yigla M, Badarna-Abu-Ria N, Tov N, Ravell-Weiller D, Rubin AH (2002) Sarcoidosis in northern Israel; clinical characteristics of 120 patients. Sarcoidosis Vasc Diffuse Lung Dis 19: 220-226. Link: https://bit.ly/3IvPsDf
Kim DS (2001) Sarcoidosis in Korea: report of the Second Nationwide Survey. Sarcoidosis Vasc Diffuse Lung Dis 18: 176-180. Link: https://bit.ly/3IuhuiF
Anantham D, Ong SJ, Chuah KL, Fook-Chong S, Hsu A, et al. (2007) Sarcoidosis in Singapore: epidemiology, clinical presentation and ethnic differences. Respirology 12: 355-360. Link: https://bit.ly/3IJ8uGu
Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, et al. (2008) Epidemiology of sarcoidosis in Japan. Eur Respir J 31: 372-379. Link: https://bit.ly/3dwNlkv
Yazaki Y, Hongo M, Y H, al e (1994) Cardiac sarcoidosis in Japan: treatment and prognosis. In: Sekiguchi M, Richardson PJ, etd Prognosis nad Treatment of Cardiomyopathy and Myoarditis Tokyo: Univ of Tokyo Press 341-53.
Sekiguchi M, Yazaki Y, Isobe M, Hiroe M (1996) Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 10: 495-510. Link: https://bit.ly/3IwcIRv
Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, et al. (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11: 26-31. Link: https://bit.ly/3y7jIzF
Tachibana T, Ohmori F, Ueda E (1986) Clinical study on cardiac sarcoidosis. Ann N Y Acad Sci 465: 530-542. Link: https://bit.ly/3Gn1NYu
Gideon NM, Mannino DM (1996) Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med 100: 423-427. Link: https://bit.ly/3pFKDi3
Fleming HA (1974) Sarcoid heart disease. Br Heart J 36: 54-68. Link: https://bit.ly/3GwflBd
Sharma OP, Maheshwari A, Thaker K (1993) Myocardial sarcoidosis. Chest 103: 253-258. Link: https://bit.ly/31E61MA
Longcope WT, Freiman DG (1952) A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 31: 1-132. Link: https://bit.ly/31E63nG
Iannuzzi MC (2007) Genetics of sarcoidosis. Semin Respir Crit Care Med 28: 15-21. Link: https://bit.ly/3Dx4K76
Meyer T, Lauschke J, Ruppert V, Richter A, Pankuweit S, et al. (2008) Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology 109: 117-121. Link: https://bit.ly/3y8CTc9
Grunewald J (2010) Review: role of genetics in susceptibility and outcome of sarcoidosis. Semin Respir Crit Care Med 31: 380-389. Link: https://bit.ly/3GIAdp1
Lagana SM, Parwani AV, Nichols LC (2010) Cardiac sarcoidosis: a pathology-focused review. Arch Pathol Lab Med 134: 1039-1046. Link: https://bit.ly/3074Q7G
Yazaki Y, Isobe M, Hiramitsu S, Morimoto S, Hiroe M, et al. (1998) Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 82: 537-540. Link: https://bit.ly/3EFcZzm
Shammas RL, Movahed A (1993) Sarcoidosis of the heart. Clin Cardiol 16: 462-472. Link: https://bit.ly/307PGPA
Ishida M, Niwano S, Fujiyoshi K, Ishida K, Ako J, et al. (2021) A case with recovery from high degree atrioventricular-block with steroid therapy in cardiac sarcoidosis with AH block: a possible new sign of responder? J Cardiol Cases 23: 90-93. Link: https://bit.ly/3GvvvKP
Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, et al. (2009) Cardiac sarcoidosis. Am Heart J 157: 9-21. Link: https://bit.ly/3pF4o9F
Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, et al. (2005) Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 96: 276-282. Link: https://bit.ly/3DEwVRE
Thachil A, Christopher J, Sastry BK, Reddy KN, Tourani VK, et al. (2011) Monomorphic ventricular tachycardia and mediastinal adenopathy due to granulomatous infiltration in patients with preserved ventricular function. J Am Coll Cardiol 58: 48-55. Link: https://bit.ly/3y6Huf0
Nery PB, Beanlands RS, Nair GM, Green M, Yang J, et al. (2014) Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol 25: 875-881. Link: https://bit.ly/3ETcFgF
Fleming H (1994) Cardiac sarcoidosis. In: James DG, ed. Sarcoidosis and other granulomatous disorders. New York: Marcel Dekker 323-334.
Viles-Gonzalez JF, Pastori L, Fischer A, Wisnivesky JP, Goldman MG, et al. (2013) Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest 143: 1085-1090. Link: https://bit.ly/3rP1Rfz
Zipse MM, Sauer WH (2013) Electrophysiologic manifestations of cardiac sarcoidosis. Curr Opin Pulm Med 19: 485-492. Link: https://bit.ly/30754M4
Kosuge H, Noda M, Kakuta T, Kishi Y, Isobe M, et al. (2001) Left ventricular apical aneurysm in cardiac sarcoidosis. Jpn Heart J 42: 265-269. Link: https://bit.ly/3oBpoi0
Marks A, Anderson MH, Harrison NK (2004) Ventricular aneurysm secondary to sarcoid disease. Heart 90: 694. Link: https://bit.ly/3oDryxI
Haraki T, Ueda K, Shintani H, Hayashi T, Taki J, et al. (2002) Spontaneous development of left ventricular aneurysm in a patient with untreated cardiac sarcoidosis. Circ J 66 :519-521. Link: https://bit.ly/3DAYBXl
Pedrotti P, Ammirati E, Bonacina E, Roghi A (2015) Ventricular aneurysms in cardiac sarcoidosis: From physiopathology to surgical treatment through a clinical case presenting with ventricular arrhythmias. Int J Cardiol 186: 294-296. Link: https://bit.ly/3IxOgPE
Miyazawa K, Yoshikawa T, Takamisawa I, Mahara K, Inoue K, et al. (2014) Presence of ventricular aneurysm predicts poor clinical outcomes in patients with cardiac sarcoidosis. Int J Cardiol 177: 720-722. Link: https://bit.ly/3Dx5F7u
Desai MY, Fallert MA (2003) Rapidly progressing congestive heart failure due to cardiac sarcoidosis involving papillary muscles: a case report and brief review of the literature. Cardiol Rev 11: 163-168. Link: https://bit.ly/3rT44Xo
Raftery EB, Oakley CM, Goodwin JF (1966) Acute subvalvar mitral incompetence. Lancet 2: 360-365. Link: https://bit.ly/307Qhki
Israel RH, Poe RH (1994) Massive pericardial effusion in sarcoidosis. Respiration 61:176-180. Link: https://bit.ly/3y8XixU
Kinney E, Murthy R, Ascunce G, Donohoe R, Zelis R (1979) Pericardial effusions in sarcoidosis. Chest 76: 476-478. Link: https://bit.ly/3dBGqGu
Verkleeren JL, Glover MU, Bloor C, Joswig BC (1983) Cardiac tamponade secondary to sarcoidosis. Am Heart J 106: 601-603. Link: https://bit.ly/3GrZinJ
Angomachalelis N, Hourzamanis A, Salem N, Vakalis D, Serasli E, et al. (1994) Pericardial effusion concomitant with specific heart muscle disease in systemic sarcoidosis. Postgrad Med J 70: S8-S12. Link: https://bit.ly/3DJRCvC
Garrett J, O'Neill H, Blake S (1984) Constrictive pericarditis associated with sarcoidosis. Am Heart J 107: 394. Link: https://bit.ly/3lNgM6h
Barton JH, Tavora F, Farb A, Li L, Burke AP (2010) Unusual cardiovascular manifestations of sarcoidosis, a report of three cases: coronary artery aneurysm with myocardial infarction, symptomatic mitral valvular disease, and sudden death from ruptured splenic artery. Cardiovasc Pathol 19: e119-e123. Link: https://bit.ly/3oBRaLp
Wait JL, Movahed A (1989) Anginal chest pain in sarcoidosis. Thorax 44: 391-395. Link: https://bit.ly/3rQT10W
Lam CS, Tolep KA, Metke MP, Glockner J, Cooper LT Jr (2009) Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol 32: E68-E71. Link: https://bit.ly/3DEurTl
Ward EV, Nazari J, Edelman RR (2012) Coronary artery vasculitis as a presentation of cardiac sarcoidosis. Circulation 125: e344-e346. Link: https://bit.ly/3GruhAl
Giudicatti L, Marangou J, Nolan D, Dembo L, Baumwol J, et al. (2020) The Utility of Whole Body (18)F-FDG PET-CT in Diagnosing Isolated Cardiac Sarcoidosis: The Western Australian Cardiac Sarcoid Study. Heart Lung Circ 29: e1-e6. Link: https://bit.ly/3oEnFc4
Belperio JA, Shaikh F, Abtin F, Fishbein MC , Saggar R ,et al. (2021) Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement. EClinicalMedicine 37: 100966. Link: https://bit.ly/3oEW22x
Ohara K, Okubo A, Kamata K, Sasaki H, Kobayashi J, et al. (1993) Transbronchial lung biopsy in the diagnosis of suspected ocular sarcoidosis. Arch Ophthalmol 111: 642-644. Link: https://bit.ly/3EHClg6
Chauvelot P, Skanjeti A, Jamilloux Y, de Parisot A, Broussolle C, et al. (2019) (18)F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan. Br J Ophthalmol 103: 1650-1655. Link: https://bit.ly/3dvvGcS
Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, et al. (2011) Diagnosing isolated cardiac sarcoidosis. J Intern Med 270: 461-468. Link: https://bit.ly/3y8rtoU
Ekstrom K, Lehtonen J, Nordenswan HK, Mäyränpää MI, Räisänen-Sokolowski A, et al. (2019) Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J 40: 3121-3128. Link: https://bit.ly/3y8x8eu
Hiraga H, Iwai K, Hiroe M, Omori F, Sekiguchi M, et al. (1993) Guidelines for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases. In: Tokyo: The Japanese Ministry of Health and Ministry 23-24.
Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H (1999) Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16: 75-86. Link: https://bit.ly/3pFnYlY
Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, et al. (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11: 1305-1323. Link: https://bit.ly/3lKJV20
Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, et al. (1995) Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 107: 330-334. Link: https://bit.ly/3oAe7yB
White JA, Rajchl M, Butler J, Thompson RT, Prato FS, et al. (2013) Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease. Circulation 127: e639- e641. Link: https://bit.ly/33cBUwj
Youssef G, Leung E, Mylonas I, Nery P, Williams K, et al. (2012) The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 53: 241-248. Link: https://bit.ly/3rMZ7iH
Akbar JJ, Meyer CA, Shipley RT, Vagal AS (2008) Cardiopulmonary imaging in sarcoidosis. Clin Chest Med 29: 429-443. Link: https://bit.ly/3oxihav
Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS) (1999) The European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160: 736-755. Link: https://bit.ly/3pFnBrA
Gibbons WJ, Levy RD, Nava S, Malcolm I, Marin JM, et al. (1991) Subclinical cardiac dysfunction in sarcoidosis. Chest 100: 44-50. Link: https://bit.ly/3Dx4EfD
Thunell M, Bjerle P, Stjernberg N (1983) ECG abnormalities in patients with sarcoidosis. Acta Med Scand 213: 115-118. Link: https://bit.ly/3Iw1zjK
Darlington P, Gabrielsen A, Sorensson P, Cederlund K, Eklund A, et al. (2014) Cardiac involvement in Caucasian patients with pulmonary sarcoidosis. Respir Res 15: 15. Link: https://bit.ly/3dw9rU1
Martusewicz-Boros MM, Boros PW, Wiatr E, Zych J, Piotrowska-Kownacka D, et al. (2016) Prevalence of cardiac sarcoidosis in white population: a case-control study: Proposal for a novel risk index based on commonly available tests. Medicine (Baltimore) 95: e4518. Link: https://bit.ly/30biI0U
Winters SL, Cohen M, Greenberg S, Stein B, Curwin J, et al. (1991) Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 18: 937-943. Link: https://bit.ly/3EzTlVu
Angomachalelis N, Hourzamanis A, Vamvalis C, Gavrielides A (1992) Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis. Postgrad Med J 68: S52- S56. Link: https://bit.ly/3y5eAMg
Nagano N, Nagai T, Sugano Y, Morita Y, Asaumi Y, et al. (2015) Association Between Basal Thinning of Interventricular Septum and Adverse Long-Term Clinical Outcomes in Patients With Cardiac Sarcoidosis. Circ J 79: 1601-1608. Link: https://bit.ly/3IuZqoi
Di Stefano C, Bruno G, Arciniegas Calle MC, Acharya GA, Fussner LM, et al. (2020) Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis. BMC Cardiovasc Disord 20: 21. Link: https://bit.ly/3Gmli3x
Orii M, Hirata K, Tanimoto T, Shiono Y, Shimamura K, et al. (2015) Myocardial Damage Detected by Two-Dimensional Speckle-Tracking Echocardiography in Patients with Extracardiac Sarcoidosis: Comparison with Magnetic Resonance Imaging. J Am Soc Echocardiogr 28: 683-691. Link: https://bit.ly/3dxCvuk
Schouver ED, Moceri P, Doyen D, Tieulie N, Queyrel V, et al. (2017) Early detection of cardiac involvement in sarcoidosis with 2-dimensional speckle-tracking echocardiography. Int J Cardiol 227: 711-716. Link: https://bit.ly/3GpeYYT
Tigen K, Sunbul M, Karaahmet T, Tasar O, Dundar C, et al. (2015) Early Detection of Bi-ventricular and Atrial Mechanical Dysfunction Using Two-Dimensional Speckle Tracking Echocardiography in Patients with Sarcoidosis. Lung 193: 669-675. Link: https://bit.ly/3Iz8KHN
Tawarahara K, Kurata C, Okayama K, Kobayashi A, Yamazaki N (1992) Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J 124: 1383-1384. Link: https://bit.ly/3ye48SU
Tellier P, Paycha F, Antony I, Nitenberg A, Valeyre D, et al. (1988) Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 85: 189-193. Link: https://bit.ly/3y4sqyD
Yamamoto N, Gotoh K, Yagi Y (1993) Thallium-201 myocardial SPECT findings at rest in sarcoidosis. Ann Nucl Med 7: 97-103. Link: https://bit.ly/3y5J3K5
Mana J (1997) Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med 18: 799-811. Link: https://bit.ly/3pH1L7j
Tellier P, Valeyre D, Nitenberg A, Foult JM, Bedig G, et al. (1985) Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med 11: 201-204. Link: https://bit.ly/3DBDJPZ
Yang Y, Safka K, Graham JJ, Roifman I, Zia MI, et al. (2013) Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis. J Magn Reson Imaging 39: 609-616. Link: https://bit.ly/3lM03Ae
Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, et al. (2018) Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. JACC Cardiovasc Imaging 11: 94-107. Link: https://bit.ly/3Gm8E4s
Mostard RL, Verschakelen JA, van Kroonenburgh MJ, Nelemans PJ, Wijnen PA, et al. (2013) Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis. Respir Med 107: 439-447. Link: https://bit.ly/3lHE7Gf
Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, et al. (2007) Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 132: 1949-1953. Link: https://bit.ly/334tZkt
Sobic-Saranovic D, Artiko V, Obradovic V (2013) FDG PET imaging in sarcoidosis. Semin Nucl Med 43: 404-411. Link: https://bit.ly/31MS7I0
Mostard RL, Voo S, van Kroonenburgh MJ, et al. (2011) Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med 105: 1917-1924. Link: https://bit.ly/3ovoGmt
Mc Ardle BA, Leung E, Ohira H, Cocker MS, DeKemp RA, et al. (2013) The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis. J Nucl Cardiol 20: 297-306. Link: https://bit.ly/3EAbDWs
Nishiyama Y, Yamamoto Y, Fukunaga K, Takinami H, Iwado Y, et al. (2006) Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 47: 1571-1576. Link: https://bit.ly/3Is7dmW
Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, et al. (2004) Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45: 1989-1998. Link: https://bit.ly/3lNHAmK
Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, et al. (2003) Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 44: 1030-1036. Link: https://bit.ly/306IIdD
Blankstein R, Osborne M, Naya M, Waller A, Kim CK, et al. (2014) Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 63: 329-336. Link: https://bit.ly/3ECRHCv
Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, et al. (2017) Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol 24: 86-99. Link: https://bit.ly/3pFTEYi
Schatka I, Bengel FM (2014) Advanced Imaging of Cardiac Sarcoidosis. J Nucl Med 55: 99-106. Link: https://bit.ly/3rNb1cG
Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, et al. (2005) Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26: 1538-1543. Link: https://bit.ly/3lG6Dbx
Braun JJ, Kessler R, Constantinesco A, Imperiale A (2008) 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 35: 1537-1543. Link: https://bit.ly/3ovWwYC
Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, et al. (2016) Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 43: 259-269. Link: https://bit.ly/31FNaka
Bartlett ML, Bacharach SL, Voipio-Pulkki LM, Dilsizian V (1995) Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects. J Nucl Med 36: 188-195. Link: https://bit.ly/3dxMUq4
Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, et al. (2008) Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 35: 933-941. Link: https://bit.ly/3EFRyhx
Galati G, Leone O, Rapezzi C (2014) The difficult diagnosis of isolated cardiac sarcoidosis: usefulness of an integrated MRI and PET approach. Heart 100: 89-90. Link: https://bit.ly/3dvXuhm
Ordovas KG, Higgins CB (2011) Delayed contrast enhancement on MR images of myocardium: past, present, future. Radiology 261: 358-374. Link: https://bit.ly/3dw8zyJ
Ohira H, Tsujino I, Yoshinaga K (2011) 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 38: 1773-1783. Link: https://bit.ly/3DGXlSU
Vignaux O (2005) Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184: 249-254. Link: https://bit.ly/3rIiCZX
Giesbrandt KJ, Bolan CW, Shapiro BP, Edwards WD, Mergo PJ (2013) Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation. AJR Am J Roentgenol 200: W274-282. Link: https://bit.ly/3GnzxFd
Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, et al. (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683-1690. Link: https://bit.ly/3dyirbb
Smedema JP, Ainslie G, Crijns H (2020) Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 63: 271-307. Link: https://bit.ly/3m6zPJ5
Chandra M, Silverman ME, Oshinski J, Pettigrew R (1996) Diagnosis of cardiac sarcoidosis aided by MRI. Chest 110: 562-565. Link: https://bit.ly/3y7k21h
Shimada T, Shimada K, Sakane T, Ochiai K, Tsukihashi H, et al. (2001) Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 110: 520-527. Link: https://bit.ly/3s1B53Z
Matsuki M, Matsuo M (2000) MR findings of myocardial sarcoidosis. Clin Radiol 55: 323-325. Link: https://bit.ly/3dvWVnK
Vignaux O, Dhote R, Duboc D, Blanche P, Devaux JY, et al. (2002) Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 26: 762-767. Link: https://bit.ly/3EB09lH
Ichinose A, Otani H, Oikawa M, Takase K, Saito H, et al. (2008) MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol 191: 862-869. Link: https://bit.ly/3lKIjW0
Matoh F, Satoh H, Shiraki K, Odagiri K, Saitoh T, et al. (2008) The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J Cardiol 51: 179-188. Link: https://bit.ly/3DuDRkh
Watanabe E, Kimura F, Nakajima T, Hiroe M, Kasai Y, et al. (2013) Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function. J Thorac Imaging 28: 60-66. Link: https://bit.ly/3067jzn
Yoshida A, Ishibashi-Ueda H, Yamada N, Kanzaki H, Hasegawa T, et al. (2013) Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure. Eur J Heart Fail 15: 166-175. Link: https://bit.ly/31yjGFc
Patel AR, Klein MR, Chandra S, Spencer KT, Decara JM, et al. (2011) Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail 13: 1231-1237. Link: https://bit.ly/3GkfnMe
Cheong BY, Muthupillai R, Nemeth M, Lambert B, Dees D, et al. (2009) The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis. Vasc Diffuse Lung Dis 26: 39-46. Link: https://bit.ly/3dMcAzr
Ishibashi K, Takeda M, Yamahara Y (2013) Clinical utility of a magnetic resonance-conditional pacemaker in a patient with cardiac sarcoidosis. Intern Med 52: 1341-1345. Link: https://bit.ly/3DEWeTn
Hulten E, Agarwal V, Cahill M, Cole G, Vita T, et al. (2016) Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis. Circ Cardiovasc Imaging 9: e005001. Link: https://bit.ly/3dMcA2p
Nagai T, Kohsaka S, Okuda S, Anzai T, Asano K, et al. (2014) Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation. Chest 146: 1064-1072. Link: https://bit.ly/31EkUOH
Ekstrom K, Lehtonen J, Hanninen H, Kandolin R, Kivisto S, et al. (2016) Magnetic Resonance Imaging as a Predictor of Survival Free of Life-Threatening Arrhythmias and Transplantation in Cardiac Sarcoidosis. J Am Heart Assoc 5: e003040. Link: https://bit.ly/3GqPWJ6
Ekstrom K, Raisanen-Sokolowski A, Lehtonen J, Nordenswan HK, Mayranpaa MI, et al. (2020) Idiopathic giant cell myocarditis or cardiac sarcoidosis? A retrospective audit of a nationwide case series. ESC Heart Fail 7: 1362-1370. Link: https://bit.ly/3EzRLTy
Franke KB, Marshall H, Kennewell P, Pham HD, Tully PJ, et al. (2021) Risk and predictors of sudden death in cardiac sarcoidosis: A systematic review and meta-analysis. Int J Cardiol 328: 130-140. Link: https://bit.ly/3y3grBn
Greulich S, Kitterer D, Latus J, Aguor E, Steubing H, et al. (2016) Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction. Circ Cardiovasc Imaging 9: e005022. Link: https://bit.ly/3rLGvj7
Crouser ED, Ono C, Tran T, He X, Raman SV (2014) Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am J Respir Crit Care Med 189: 109-112. Link: https://bit.ly/3y9CzKf
Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, et al. (2017) T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis. Radiology 285: 63-72. Link: https://bit.ly/3oI1phv
Wilkoff BL, Bello D, Taborsky M, Vymazal J, Kanal E, et al. (2011) Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 8: 65-73. Link: https://bit.ly/33bip7n
Ishikawa T, Kondoh H, Nakagawa S, Koiwaya Y, Tanaka K (1984) Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest 85: 445-447. Link: https://bit.ly/3DzH02b
Lorell B, Alderman EL, Mason JW (1978) Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol 42: 143-146. Link: https://bit.ly/3Iux2mq
Ratner SJ, Fenoglio JJ, Ursell PC (1986) Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 90: 528-533. Link: https://bit.ly/31HhfQ4
Sekiguchi M, Numao Y, Imai M, Furuie T, Mikami R (1980) Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Jpn Circ J 44: 249-263. Link: https://bit.ly/3355fZr
Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, et al. (1999) Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 138: 299-302. Link: https://bit.ly/31EkXtR
Liang JJ, Hebl VB, DeSimone CV, Madhavan M, Nanda S, et al. (2014) Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis. JACC Heart Fail 2: 466-473. Link: https://bit.ly/3rQhCmu
Frustaci A, Russo MA, Chimenti C (2013) Diagnostic contribution of left ventricular endomyocardial biopsy in patients with clinical phenotype of hypertrophic cardiomyopathy. Hum Pathol 44: 133-141. Link: https://bit.ly/3rLGmfz .
Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, et al. (1999) The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) 78: 270-283. Link: https://bit.ly/3lNc6x7
Veinot JP (2002) Diagnostic endomyocardial biopsy pathology: secondary myocardial diseases and other clinical indications - a review. Can J Cardiol 18: 287-296.
Dechering DG, Kochhauser S, Wasmer K, Zellerhoff S, Pott C, et al. (2013) Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 10: 158-164. Link: https://bit.ly/31vSE1f
Quarta G, Husain SI, Flett AS, Sado DM, Chao CY, et al. (2013) Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 15: 16. Link: https://bit.ly/3rMDpvi
Yoshizawa S, Kato TS, Mancini D, Marboe CC (2013) Outcome of patients having heart transplantation for lymphocytic myocarditis. Am J Cardiol 112: 405-410. Link: https://bit.ly/3y2xraU
Mavrogeni S, Sfikakis PP, Gialafos E, Bratis K, Karabela G, et al. (2013) Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken) 66: 104-112. Link: https://bit.ly/3rS3pFT
Miszalski-Jamka T, Szczeklik W, Sokolowska B, Karwat K, Belzak K, et al. (2013) Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener's) in patients with normal electrocardiograms and transthoracic echocardiography. Int J Cardiovasc Imaging 29: 843-853. Link: https://bit.ly/3ye2O2o
Nguyen Y, Guillevin L (2018) Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss). Semin Respir Crit Care Med 39: 471-481. Link: https://bit.ly/3GnyPb1
Kang EJ, Kim SM, Choe YH, Lee GY, Lee KN, et al. (2013) Takayasu Arteritis: Assessment of Coronary Arterial Abnormalities with 128-Section Dual-Source CT Angiography of the Coronary Arteries and Aorta. Radiology 270: 74-81. Link: https://bit.ly/3y3Nh50
Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, et al. (2013) Cardiac amyloidosis: Updates in diagnosis and management. Arch Cardiovasc Dis 106: 528-540. Link: https://bit.ly/3lL0RW3
Marques N, Gan VC, Leo YS (2013) Dengue myocarditis in Singapore: two case reports. Infection 41: 709-714. Link: https://bit.ly/3oAbVXT
Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL (2013) Council on Chagas Disease of the Interamerican Society of C. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol 62: 767-776. Link: https://bit.ly/3pGfRWr
Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, et al. (2012) Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol 59: 37-45. Link: https://bit.ly/3EAZyjX
Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, et al. (2008) Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133: 1426-1435. Link: https://bit.ly/3pFmdoS
Mehta D, Mori N, Goldbarg SH, Lubitz S, Wisnivesky JP, et al. (2011) Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol 4: 43-48. Link: https://bit.ly/31BljBK
Uusimaa P, Ylitalo K, Anttonen O, Kerola T, Virtanen V, et al. (2008) Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 10: 760-766. Link: https://bit.ly/3Iw5E7G
Riezzo I, Ventura F, D'Errico S, Neri M, Turillazzi E, et al. (2009) Arrhythmogenesis and diagnosis of cardiac sarcoidosis. An immunohistochemical study in a sudden cardiac death. Forensic Sci Int 183: e1-5. Link: https://bit.ly/3Ipphy9
Kato Y, Morimoto S, Uemura A, Hiramitsu S, Ito T, et al. (2003) Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 20: 133-137. Link: https://bit.ly/3lLkcGq
Shabetai R (2000) Sarcoidosis and the Heart. Curr Treat Options Cardiovasc Med 2: 385-398.
Padilla ML (2010) Cardiac Sarcoidosis. In: Sarcoidosis (RP Baughman, Ed), informaUSA, New York, NY 210: 515-551.
Mezaki T, Chinushi M, Washizuka T, Furushima H, Chinushi Y, et al. (2001) Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis. Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med 40: 731-735. Link: https://bit.ly/3DzKWjm
Huang PL, Brooks R, Carpenter C, Garan H (1991) Antiarrhythmic therapy guided by programmed electrical stimulation in cardiac sarcoidosis with ventricular tachycardia. Am Heart J 121: 599-601. Link: https://bit.ly/3dyhEHf
Jefic D, Joel B, Good E, Morady F, Rosman H, et al. (2009) Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm 6: 189-195. Link: https://bit.ly/3lNonSq
Hiramastu S, Tada H, Naito S, Oshima S, Taniguchi K (2009) Steroid treatment deteriorated ventricular tachycardia in a patient with right ventricle-dominant cardiac sarcoidosis. Int J Cardiol 132: e85- e87. Link: https://bit.ly/31BhRXX
Stees CS, Khoo MS, Lowery CM, Sauer WH (2011) Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol 22: 210-213. Link: https://bit.ly/3yjxUWt
Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, et al. (2012) Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 23: 925-929. Link: https://bit.ly/3pyHOiQ
Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, et al. (2012) Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 9: 884-891. Link: https://bit.ly/31KQGd8
Paz HL, McCormick DJ, Kutalek SP, Patchefsky A (1994) The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis. Chest 106: 1603-1607. Link: https://bit.ly/3GqMLkp
Takada K, Ina Y, Yamamoto M, Satoh T, Morishita M (1994) Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis 11: 113-117. Link: https://bit.ly/3oAMepZ
Chinushi M, Mezaki T, Aoki Y, Nakagawa I, Washizuka T,et al. (2000) Demonstration of transient entrainment in monomorphic sustained ventricular tachycardia associated with cardiac sarcoidosis. Jpn Circ J 64: 635-637. Link: https://bit.ly/3Gtw4VO
Birnie DH, Sauer WH, Judson MA (2016) Consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart 102: 411-414. Link: https://bit.ly/3pEhZOq
Mohsen A, Jimenez A, Hood RE, Dickfeld T , Saliaris A, et al. (2014) Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol 25: 171-176. Link: https://bit.ly/3rL8NKN
Kron J, Sauer W, Schuller J, Bogun F, Crawford T, et al. (2013) Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace 15: 347-354. Link: https://bit.ly/3DE5d7i
Takenaka S, Kobayashi Y, Nagai T, Kato Y, Komoriyama H, et al. (2021) Applicability of the AHA/ACC/HRS Guideline for Implantable Cardioverter Defibrillator Implantation in Japanese Patients With Cardiac Sarcoidosis. JACC Clin Electrophysiol. Link: https://bit.ly/3y7MbVX
Sugisaki K, Yamaguchi T, Nagai S, Ohmiti M, Takenaka S, et al. (2003) Clinical characteristics of 195 Japanese sarcoidosis patients treated with oral corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis 20: 222-226. Link: https://bit.ly/3EHDi8a
Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, et al. (2011) Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol 16: 140-147. Link: https://bit.ly/3oEfTyS
Yodogawa K, Seino Y, Shiomura R, Takahashi K, Tsuboi I, et al. (2013) Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. J Cardiol. Link: https://bit.ly/3pCqyt7
Kaida T, Inomata T, Minami Y, Yazaki M, Fujita T, et al. (2018) Importance of Early Diagnosis of Cardiac Sarcoidosis in Patients with Complete Atrioventricular Block. Int Heart J 59: 772-778. Link: https://bit.ly/3DJVv3G
Nabeta T, Hara M, Naruke T, Maemura K, Oki T, et al. (2021) Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis. J Arrhythm 37: 1093-1100. Link: https://bit.ly/3GqcWYC
Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB (2013) Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol 29: 1034-1041. Link: https://bit.ly/3rT7KIG
Pierre-Louis B, Prasad A, Frishman WH (2009) Cardiac manifestations of sarcoidosis and therapeutic options. Cardiol Rev 17: 153-158. Link: https://bit.ly/3rPTdxy
Baughman R, Lower EE (1999) A clinical approach to the use of methotrexate for sarcoidosis. Thorax 54: 742-746. Link: https://bit.ly/3yb9TAt
Muller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U (1999) Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 14: 1117-1122. Link: https://bit.ly/31E8AOR
Lazar CA, Culver DA (2010) Treatment of sarcoidosis. Semin Respir Crit Care Med 31: 501-518. Link: https://bit.ly/3IBXvyj
Demeter SL (1988) Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest 94: 202-203. Link: https://bit.ly/3DxaGgk
Barnabe C, McMeekin J, Howarth A, Martin L (2008) Successful treatment of cardiac sarcoidosis with infliximab. J Rheumatol 35: 1686-1687. Link: https://bit.ly/3IB1N94
Vorselaars ADM, Wuyts WA, Vorselaars VMM, Zanen P, Deneer VHM, et al. (2013) Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest 144: 805-812. Link: https://bit.ly/3dyWf0J
Baughman RP, Lower EE (2004) Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 21: 43-48. Link: https://bit.ly/3lKOae0
Sahoo DH, Bandyopadhyay D, Xu M, Pearson K, Parambil JG, et al. (2011) Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J 38: 1145-1150. Link: https://bit.ly/3DECcsq
Brill AK, Ott SR, Geiser T (2013) Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study. Respiration 86: 376-383. Link: https://bit.ly/3ozLWzS
Bitoun S, Bouvry D, Borie R, Mahevas M, Sacre K, et al. (2016) Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil. Neurology 87: 2517-2521. Link: https://bit.ly/3dz8xpP
Stievenart J, Le Guenno G, Ruivard M, Rieu V, Andre M, et al. (2021) Case Report: TNFalpha Antagonists Are an Effective Therapy in Cardiac Sarcoidosis. Front Cardiovasc Med 8: 676407. Link: https://bit.ly/3lKOdGI
Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT, et al. (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107: 3133-3140. Link: https://bit.ly/3rX4egi
Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, et al (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109: 1594-1602. Link: https://bit.ly/3EGoRkv
Vorselaars AD, Crommelin HA, Deneer VH, Meek B, Claessen AM, et al. (2015) Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis. Eur Respir J 46: 175-185. Link: https://bit.ly/3oBOEVk
Rosenthal DG, Parwani P, Murray TO, Petek BJ, Benn BS, et al. (2019) Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis. J Am Heart Assoc 8: e010952. Link: https://bit.ly/31JTs22
Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, et al. (2017) Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. Neurology 89: 2092-2100. Link: https://bit.ly/3rN9vae
Milman N, Graudal N, Loft A, Mortensen J, Larsen J, et al. (2012) Effect of the TNF-alpha inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET. Clin Respir J 6: 238-247. Link: https://bit.ly/3EL2WZK
Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, Maucort-Boulch D, Marquet A, et al. (2017) Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients. Semin Arthritis Rheum 47: 288-294. Link: https://bit.ly/3EGngLs
Utz JP, Limper AH, Kalra S, Specks U, Scott JP, et al. (2003) Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124: 177-185. Link: https://bit.ly/3ymwwCt
Baughman RP, Lower EE, Bradley DA, Raymond LA, Kaufman A (2005) Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest 128: 1062-1047. Link: https://bit.ly/3oEgKj4
Crommelin HA, van der Burg LM, Vorselaars AD, Drent M, van Moorsel CH, et al. (2016) Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab. Respir Med 115: 72-77. Link: https://bit.ly/3GoYy2M
Bomprezzi R, Pati S, Chansakul C, Vollmer T (2010) A case of neurosarcoidosis successfully treated with rituximab. Neurology 75: 568-570. Link: https://bit.ly/307xOEr
Krause ML, Cooper LT, Chareonthaitawee P, Amin S (2016) Successful use of rituximab in refractory cardiac sarcoidosis. Rheumatology (Oxford) 55: 189-191. Link: https://bit.ly/3pEjgVI
Damsky W, Thakral D, McGeary MK, Leventhal J, Galan A, et al. (2020) Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare. J Am Acad Dermatol 82: 612-621. Link: https://bit.ly/3dBjcjL
Rotenberg C, Besnard V, Brillet PY, Giraudier S, Nunes H, et al. (2018) Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia. Eur Respir J 52. Link: https://bit.ly/3pI9gL0
Lynch III J, Hunninghake G (1992) Sarcoidosis. In: Lichtenstein LM, Fauci AS, eds. Current Therapy in Allergy, Immunology and Rheumatology. Philadelphia: B.C.Decker 243-251.
Lynch III JP, Kazerooni EA, Gay SE (1997) Pulmonary sarcoidosis. Clin Chest Med 18: 755-785. Link: https://bit.ly/31GfK4O
Lynch III J, Baughman R, Sharma O (1998) Extrapulmonary sarcoidosis. Semin Respir Infect 13: 229-254. Link: https://bit.ly/3IwhNcx
Lynch JP 3rd, Ma YL, Koss MN, White ES (2007) Pulmonary sarcoidosis. Semin Respir Crit Care Med 28: 53-74. Link: https://bit.ly/3Gn8Dgw
Lynch JP 3rd, McCune WJ (1997) Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 155: 395-420. Link: https://bit.ly/3IBYgHF
Wang T, Weigt SS, Belperio JA, Lynch JP (2011) Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring. Semin Respir Crit Care Med 32: 346-370. Link: https://bit.ly/3dAMxLq
Jain A, Starek PJ, Delany DL (1990) Ventricular tachycardia and ventricular aneurysm due to unrecognized sarcoidosis. Clin Cardiol 13: 738-740. Link: https://bit.ly/3pYhsqT
Lull RJ, Dunn BE, Gregoratos G, Cox WA, Fisher GW (1972) Ventricular aneurysm due to cardiac sarcoidosis with surgical cure of refractory ventricular tachycardia. Am J Cardiol 30: 282-287. Link: https://bit.ly/3rPXZeu
Harris IM, Guarino R (1994) Cardiac sarcoidosis: a new approach to treatment. Cardiovasc Surg 2: 420-422. Link: https://bit.ly/3EHetsN
Perkel D, Czer LS, Morrissey RP, Ruzza A, Rafiei M, et al. (2013) Heart transplantation for end-stage heart failure due to cardiac sarcoidosis. Transplant Proc 45: 2384-2386. Link: https://bit.ly/3lKORUE
Chang TI, Chi NH, Chou NK, Tsao CI, Yu HY, et al. (2012) Isolated cardiac sarcoidosis in heart transplantation. Transplant Proc 44: 903-906. Link: https://bit.ly/3lNRUeD
Zaidi AR, Zaidi A, Vaitkus PT (2007) Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 26: 714-717. Link: https://bit.ly/3oClKV9
Milman N, Andersen CB, Mortensen SA, Sander K (2008) Cardiac sarcoidosis and heart transplantation: a report of four consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis 25: 51-59. Link: https://bit.ly/3096Mg5
Donsky AS, Escobar J, Capehart J, Roberts WC (2002) Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol 89: 1447-1450.
Akashi H, Kato TS, Takayama H, Naka Y, Farr M, et al. (2012) Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation--single-center retrospective analysis. J Cardiol 60: 407-410. Link: https://bit.ly/3oB4IXs
Genovese L, Dey AK, Cole RT, Cooper LB, Desai S, et al. (2021) Fulminant cardiogenic shock due to cardiac sarcoidosis. J Community Hosp Intern Med Perspect 11: 673-677. Link: https://bit.ly/3GwJQXH
Makhdumi M, Assar MD, Meyer DM, Roberts WC (2021) Cardiac sarcoidosis diagnosed after orthotopic heart transplantation and clinically mimicking arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Pathol 56: 107390. Link: https://bit.ly/3oB4NKK
Bobbio E, Bjorkenstam M, Nwaru BI, Giallauria F, Hessman E, et al. (2021) Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis. Clin Res Cardiol. Link: https://bit.ly/3GqSqHb
Rosenthal DG, Anderson ME, Petek BJ, Arnett DM, Bravo PE, et al. (2018) Invasive Hemodynamics and Rejection Rates in Patients With Cardiac Sarcoidosis After Heart Transplantation. Can J Cardiol 34: 978-982. Link: https://bit.ly/3lPXcGp
Khan R, Tweedie EJ, Pflugfelder PW, White JA (2010) Cardiac sarcoid in a heart transplant recipient: detection with cardiac magnetic resonance imaging. Transplant Proc 42: 1976-1978. Link: https://bit.ly/3y8f4kM
Luk A, Lee A, Ahn E, Soor GS, Ross HJ, et al. (2010) Cardiac sarcoidosis: recurrent disease in a heart transplant patient following pulmonary tuberculosis infection. Can J Cardiol 26: e273-e275. Link: https://bit.ly/31KS8w6
Yager JE, Hernandez AF, Steenbergen C, Persing B , Russell SD ,et al. (2005) Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant 24: 1988-1990. Link: https://bit.ly/3EDCQYd
Wiltshire S, Nadel J, Meredith T, Iglesias CK, Qiu MR, et al. (2021) Twice Bitten, Thrice Shy: A Case of Recurrent Isolated Cardiac Sarcoidosis in the Transplanted Heart. JACC Case Rep 3: 427-432. Link: https://bit.ly/307W7SK
Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, et al. (1992) Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 11: 367-369. Link: https://bit.ly/31NeMnd